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Background The CoPanFlu-France household cohort was set up in
2009 to identify risk factors of infection by the pandemic A/H1N1
(H1N1pdm09) virus in the general population.
Objectives To investigate the determinants of infection during the
2010–2011 season, the first complete influenza season of study
follow-up for this cohort.
Patients/Methods Pre- and post-epidemic blood samples were
collected for all subjects, and nasal swabs were obtained in all
subjects from households where an influenza-like illness was
reported. Cases were defined as either a fourfold increase in the
serological titer or a laboratory-confirmed H1N1pdm09 on a nasal
swab, with either RT-PCR or multiplex PCR. Risk factors for
H1N1pdm09 infections were explored, without any pre-specified
hypothesis, among 167 individual, collective and environmental
covariates via generalized estimating equations modeling. We
adopted a multimodel selection procedure to control for model
selection uncertainty.
Results This analysis is based on a sample size of 1121 subjects.
The final multivariable model identified one risk factor (history of
asthma, OR = 217; 95% CI: 102–462) and three protective factors:
pre-epidemic serological titer (OR = 051 per doubling of the titer;
95% CI: 039–067), green tea consumption a minimum of two
times a week (OR = 039; 95% CI: 018–084), and proportion of
subjects in the household always covering their mouth while
coughing/sneezing (OR = 093 per 10% increase; 95% CI: 086–
100).
Conclusion This exploratory study provides further support of
previously reported risk factors and highlights the importance of
collective protective behaviors in the household. Further analyses
will be conducted to explore these findings.
Keywords Cohort studies, France, influenza A virus, H1N1 sub-
type, risk factor.
Please cite this paper as: Delabre et al. (2015) Risk factors of pandemic influenza A/H1N1 in a prospective household cohort in the general population: results
from the CoPanFlu-France cohort. Influenza and Other Respiratory Viruses 9(1), 43–50.
Introduction
Households are useful epidemiological settings to study
influenza infection as an estimated 30% of influenza
infections are transmitted within the home.1 Risk factors
for infection by the novel influenza A/H1N1 pandemic virus
(H1N1pdm09) have been studied in households since its
identification in spring 2009, and findings have been
summarized in a review.2 These household studies, however,
have largely focused on a limited number of determinants,
which mainly rely on sociodemographic characteristics,
contact behaviors, or efficacy of prevention measures.3–7
Furthermore, identified risk factors may not be generalized
to the general population as they were largely based on data
from case-ascertained studies, in which households including
an “index case” are recruited and followed up.
Influenza A/H1N1pdm09 has continued to circulate in
conjunction with influenza A/H3N2 and influenza B since
the 2009 pandemic. Identification of the determinants of
H1N1pdm09 infection, which are not well understood in the
context of cocirculation with other seasonal viruses, is
important for guiding future public health measures. The
DOI:10.1111/irv.12294
www.influenzajournal.com
Original Article
ª 2014 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd. 43
This is an open access article under the terms of the Creative Commons Attribution License, which permits use,
distribution and reproduction in any medium, provided the original work is properly cited.
CoPanFlu-France cohort, established to study the risk of
influenza infection in households in the general population,
presents the opportunity to identify the determinants of
H1N1pdm09 infection using an large collection of data from
both questionnaires and biological samples.8
Risk factors associated with high post-epidemic titer
following the 2009–2010 pandemic season have previously
been reported for this cohort.9 Here, we present an analysis
relying on the first prospective year of study data to identify
factors associated with H1N1pdm09 infections over the
2010–2011 season, exploring a large panel of covariates
possibly involved in H1N1pdm09 transmissions.
Materials and methods
Study design and participants
Study design and procedures have been previously pub-
lished.8,9 From December 2009 to July 2010, a total of 601
families or households (1450 subjects) were included in the
CoPanFlu-France cohort. According to the 2009 census, this
cohort was overall representative of the French population
according to age, sex, household size, urban area size, and
socioeconomic distribution.8
Over the 2-year follow-up period, annual study visits
were conducted by study nurses, which included data
collection via questionnaires and blood samples for all
enrolled subjects. Additional study visits were programmed
when a household declared an influenza-like illness (ILI) or
a recent vaccination against influenza via an active auto-
mated surveillance system. ILI was defined as fever
(≥378°C) in addition to cough and/or sore throat. Up to
three ILI visits were conducted in the 12 days following
symptoms debut; virological samples with nasal swabs were
collected for all household members, regardless of their
symptom status.
This study focuses on the first year of follow-up (2010–
2011) during which the influenza epidemic season in
France began on 20 December 2010 and ended 20
February 2011.10
We selected participants with a pre-epidemic visit between
9 October 2010 and 6 December 2010 and a post-epidemic
visit between 15 June 2011 and 26 January 2012 (1 week
before the subsequent 2011–2012 influenza epidemic sea-
son10). Subjects who had reported a vaccination between the
pre- and post-epidemic samples, or within the 2 weeks
before the pre-epidemic sample, were excluded from the
analysis to avoid misclassification. Households were con-
tacted on a weekly basis from 15 September 2010 to 15 April
2011 via the active automated surveillance system to detect
household cases of ILI and trigger ILI visits. Written
informed consent was obtained for all enrolled subjects.8
Variables
Case definition
Influenza infection with the H1N1pdm09 virus during the
2010–2011 season was the primary outcome for this study.
Infected subjects were defined as those who either serocon-
verted [fourfold increase in hemagglutination inhibition (HI)
titer] or had laboratory-confirmed H1N1pdm09 on a nasal
swab collected during an ILI visit, using either a monoplex or
multiplex molecular detection assay.
Baseline covariates
A total of 167 variables concerning characteristics at the
individual, household, and environmental levels were col-
lected from questionnaires completed by the subjects at
inclusion and organized into five categories: (i) sociodemo-
graphic characteristics, habits, and medical history, (ii)
preventive measures, (iii) housing characteristics, (iv) social
contact information, and (v) geographic characteristics of
housing environment. In addition to the covariates studied
in the 2009 risk factors analysis,9 two new sets of covariates
were also considered in the “habits/medical history” category
for this analysis: anthropometric information (height,
weight, and body mass index) and frequency of tea/coffee
consumption. All covariates are described in Tables S1–S5.
As age has been found as a major determinant of influenza
infection risk,11 we performed sensitivity analyses stratified
by age groups (subjects under 15, aged 15–50, and over 50 at
inclusion).
Pre-epidemic titer is sometimes studied as a covariate in
risk factors analysis.12 However, subjects with an elevated
pre-epidemic titer may have been previously exposed to the
virus (or had a high level of pre-existing cross-immunity). As
most risk factors of influenza infection related to a partic-
ipant’s characteristics are likely to be consistent across
successive years, pre-epidemic HI titers can be considered
in the causal pathway between a risk factor and the outcome,
and adjustment on this titer may lead to bias. Additionally,
pre-epidemic titer was used to define seroconversions, and it
is possible that subjects with a high pre-epidemic titer may be
less likely to seroconvert after infection.13 We therefore
carried out two analyses in parallel, with and without this
variable, to assess the impact of this covariate as a risk factor
and account for a possible bias.
Laboratory procedures
The HI titer was determined as the highest dilution providing
clear inhibition of hemagglutination in two independent
readings.9 RT-PCR and multiplex PCR were used to detect
viral genome. Viral RNA was extracted from 200 ll of nasal
swab eluate using the QIAamp Viral RNA kit (Qiagen, Venlo,
Netherlands). TaqMan qRT-PCR was used targeting the
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hemagglutinin HA gene (SuperScript III Platinum).9 The
RespiFinder assay was used to simultaneously detect up to 18
respiratory viruses, including the H1N1pdm09.
Data collection regarding symptoms
During an ILI visit, the presence of the following symptoms
was collected in all subjects: cough, runny nose, sore throat,
headache, earache, muscle soreness, fatigue, nausea/vomiting,
diarrhea, eye redness, and fever (≥378°C). This information
was checked retrospectively in all subjects, regardless of already
reported symptoms, during the following annual visit. In this
analysis, we took into account the presence of a symptom if it
was reported at least once in a period of 10 days before and
after the virus was identified on a swab, or anytime between the
blood samples for subjects with serologically defined infection.
Statistical methods
Description of baseline covariates and symptoms
Infected and non-infected subjects were compared using the
Mann–Whitney U-test for continuous covariates and the
Fisher exact test for categorical covariates. Sensitivities of
symptoms with their 95% confidence interval (CI) were
estimated with the binomial exact test. The pre-epidemic
geometric mean titer (GMT) for HI assays was estimated
with regression models for interval-censored data with
respect for the within-household correlation.9 We estimated
the impact of post-epidemic blood sample date on serocon-
version rate via logistic regression with the use of generalized
estimating equations (GEE) with an exchangeable correlation
structure accounting for the correlation between responses of
subjects living in the same household.
Risk factors analysis
Risk factors for infection were estimated with the same
method (GEE-based logistic regression). Skewed covariates
were log-transformed to obtain normal-like distributions
(see Tables S1–S5 for details).
Simultaneous testing of a large amount of covariates yields
a type I error rate inflation likely to identify spurious
associations. To avoid this drawback, we used a multimodel
selection procedure (described in Supporting information)
to identify the most relevant covariates among which the
final multivariable model should be fitted.14 This multimodel
selection procedure accounted for model uncertainty, that is,
considered that several models could bring insightful infor-
mation without needing to focus only on the one with the
best information criterion.15
All covariates were therefore kept in the multivariable
models selection, regardless of the univariable analysis, to
avoid biases linked to univariable screening.16
Multivariable models were selected using the quasi-likeli-
hood under independence model criterion (QIC),17 and all
multivariable models were assigned a weight according to
their relative QIC, which may be interpreted as the weight of
evidence in favor of a particular model given the tested
subset of models.18
A stepwise model selection was then performed, allowing
only models with P < 005 for all factors respectively, among
these covariates to obtain the final multivariable model. To
account for missing data, this model was averaged from
estimations through 30 imputed datasets using Rubin’s
rule.19 This analysis was carried out for the whole sample and
stratified by age groups (under 15, between 15 and 50 and
over 50 years at inclusion). All analyses were performed
using R software version 2.15 (R Foundation for Statistical
Computing, Vienna, Austria).
Results
Description of infections
Among the 1450 subjects initially included in the cohort,
1318 were followed over the 2010–2011 season. Of the 240
subjects who reported vaccine receipt during the 2010–2011
season, 151 were excluded from the analysis due to reported
vaccination within the 2 weeks before, or anytime after,
collection of pre-epidemic serological sample (n = 108), or
inconclusive data regarding a subject’s vaccination status or
date of vaccination (n = 43). No significant differences were
found regarding age, sex, medical condition, household size,
urban area size, and socioeconomic categories between
these subjects and the vaccine recipients included in the
cohort. Additionally, 46 other subjects were excluded from
the analysis because their blood samples were obtained
during the subsequent epidemic period. This analysis is
based on a final sample size of 1121 subjects (498
households). A total of 256 ILI visits were carried out in
97 of these households, which included nasal swabs
collection in 275 subjects.
Pre-epidemic GMT was 528 (95% CI: 508–550).
GMT was higher in subjects under 15 years old at inclusion
(GMT: 674; 95% CI: 612–743) than in those aged
15–50 (GMT: 482; 95% CI: 456–511; P < 00001) or over
50 years old (GMT: 517; 95% CI: 486–549, P < 00001).
According to our definition, 89 subjects were infected:
H1N1pdm09 RNA was detected among 49 subjects and 48
seroconverted (only eight subjects were identified as infected
with both methods). The seroconversion rate was 163%
(95% CI: 73–297%) in subjects with detected RNA and
37% (95% CI: 27–50%) in others (P < 0001). The number
of infections per age group was 24 (107%), 36 (71%), and
29 (74%) for subjects under 15 years, 15–50 years, and over
50 years at inclusion, respectively.
We noted a decrease of the seroconversion rate over time,
according to the post-epidemic blood sample date
(OR = 083 per month; 95% CI: 072–097).
H1N1pdm09 risk factors in the general population
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Forty-eight of the 89 infected subjects (539%; 95% CI:
430–646%) reported ILI-related symptoms (Figure 1). This
rate was lower in the 48 subjects with seroconversion than in
the 41 others: 315%; 95% CI: 187–463% versus 805%;
95% CI: 651–912%, P < 00001.
Reported symptoms with their respective sensitivities were
fever ≥378°C (382%; 95% CI: 281–491%), cough (483%;
95% CI: 376–592%), runny nose (438%; 95% CI: 333–
547%), sore throat (348%; 95% CI: 250–457%), muscle
soreness (326%; 95% CI: 230–433%), fatigue (494%; 95%
CI: 387–602%), nausea/vomiting (202%; 95% CI: 124–
301%), diarrhea (124%; 95% CI: 63–210%), eye redness
(157%; 95% CI: 89–250%), and earache (112%; 95% CI:
55–197%). The sensitivity of CDC-defined ILI was 360%
(95% CI: 261–468%).
Risk factors analysis
Univariable results are given in Tables S1–S5. Analyses with
and without pre-epidemic titer as a covariate were performed
by selecting 4 and 9 multivariable models (see Tables S6–S18
for details). Among the 13 models, the covariates associated
with infections comprised of three potential risk factors
(history of asthma, history of cardiovascular disease, and
number of children sharing the same bedroom) and nine
potential protective factors (pre-epidemic serological titer,
2010–2011 influenza seasonal vaccination, proportion of
2010–2011 influenza vaccine recipients in the household,
2009–2010 pandemic vaccination, reported ILI during the
2009 pandemic wave, number of daily handwashing, mean
number of daily handwashing in the household, proportion
of household members always covering their mouth while
coughing/sneezing, and green tea consumption a minimum
of two times a week).
The final multivariable model (Table 1a) fitted from these
covariates identified one risk factor (history of asthma,
OR = 217; 95% CI: 102–462) and three protective factors:
pre-epidemic serological titer (OR = 051 per doubling of
the titer; 95% CI: 039–067), green tea consumption a
minimum of two times a week (OR = 039; 95% CI: 018–
084), and proportion of subjects in the household always
covering their mouth while coughing/sneezing (OR = 093
per 10% increase; 95% CI: 086–100). The alpha parameter
of this GEE model (intrahousehold correlation of outcomes)
was 045.
Model selection regardless of the pre-epidemic titer
identified the same other covariates as associated with the
risk of infection: history of asthma (OR = 217; 95% CI:
121–409), green tea consumption a minimum of two times
a week (OR = 048; 95% CI: 025–093), and proportion of
subjects in the household always covering their mouth while
coughing/sneezing (OR = 093 per 10% increase; 95% CI:
085–100).
ILI-related symptoms
N = 180
Seroconversions
N = 48
Detected RNA
N = 49
Other subjects
N = 900
132
318
6
2
933
Figure 1. Distribution of reported ILI-related symptoms, seroconversions,
and RNA detections in the 1121 studied subjects. ILI, influenza-like illness.
Table 1. Multivariable models
OR 95% CI P
(a) All subjects, n = 1121 (89 infected, 1032 non-infected)
Pre-epidemic titer 9 2* 051 039–067 <00001
Always covering mouth while
coughing/sneezing (household
proportion)**
093 086–100 <005
History of asthma 217 102–462 <005
Green tea consumption*** 039 018–084 <002
(b) Subjects <15 years at study inclusion, n = 505 (36 infected, 469
non-infected)
Pre-epidemic titer 9 2* 047 028–078 <001
Always covering mouth while
coughing/sneezing (household
proportion)**
078 062–097 <003
History of asthma 418 110–1586 <004
(c) Subjects between 15 and 50 years at study inclusion, n = 391 (29
infected, 362 non-infected)
Pre-epidemic titer 9 2* 047 031–071 <0001
History of asthma 304 108–877 <004
Green tea consumption*** 035 013–098 <005
(d) Subjects >50 years at study inclusion, n = 225 (24 infected, 201
non-infected)
Pre-epidemic titer 9 2* 052 032–085 <001
Always covering mouth while
coughing/sneezing (household
proportion)
087 078–098 <002
**OR per each doubling of the pre-epidemic titer.
****OR per 10% increase in proportion of subjects in the household
always covering their mouth while coughing or sneezing.
******Green tea consumption a minimum of twice a week.
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Final models based on the analysis stratified by age groups
did not identify additional factors (Table 1b–d). However,
with the exception of pre-epidemic titer, which was associ-
ated with infections in all age groups, the final models
retained different covariates: asthma was identified as a
possible risk factor in subjects under 15 and 15–50 years
only, proportion of household members always covering
their mouth while coughing/sneezing was identified only for
subjects under 15 and those over 50 years, whereas green tea
consumption was associated with infections for subjects aged
15–50 years only.
Discussion
Factors associated with H1N1pdm09 infection
The CoPanFlu cohort was designed to collect a large amount
of covariates studied simultaneously in order to identify
those likely to be involved in the transmission of influenza.
We previously identified factors associated with high post-
pandemic serological titer in a retrospective, nested case–
control analysis conducted in this cohort:9 young age,
chronic obstructive pulmonary disease, asthma, social con-
tacts at school, and the use of public transportation were
identified as possible risk factors, whereas presence of an air
humidifier in the living room was a possible protective
factor. In the present analysis, we identified factors associated
with the H1N1pdm09 infection during the 2010–2011
influenza season. Our results support previously reported
risk factors for this season, in addition to identifying a
potentially protective role of collective behaviors among
household members.
High pre-seasonal titers observed in this study were
protective against H1N1pdm09 infection, as previously
reported in other studies.12,20 This result is not surprising
as the HI titer is known as a major correlate of protection.21
The household environment has been identified as an
important factor in the transmission of influenza.22 The high
correlation between outcomes of subjects living in the same
household (alpha parameter of the GEE model) was expected
as these individuals share some risk factors in addition to
environmental (within-household) exposure to influenza
viruses.
Household efficacy studies of non-pharmaceutical inter-
ventions such as regular handwashing/hygiene and use of
face masks suggest a protective benefit if implemented in a
timely manner after symptoms are observed in the index
patient.6 Public health communications, such as the CDC’s
“Cover your Cough” campaign, heavily stress the importance
of respiratory hygiene and cough etiquette to stop influenza
transmission.23 We studied several preventive behaviors at
the household level, taking into account the impact of other
members’ behaviors for households of at least two subjects.
However, only the proportion of household members
covering their mouth while coughing was found to be a
protective factor against H1N1pdm09 infection.
Asthma was already identified as a possible risk factor for
H1N1pdm09 infection in this cohort, regarding the 2009
pandemic.9 Severity of infections observed in asthmatics24
may be due to a greater immune response,25 increasing the
probability of virus detection (ILI visits). Alternatively,
asthmatic subjects may have an increased susceptibility for
H1N1pdm09 infection;26 regardless of the virological defini-
tion of infection, the seroconversion rate is higher in
asthmatic subjects (117% versus 37%, P < 001).
Effects of green tea catechins and theanine to prevent ILI
have been demonstrated in a double-blind randomized
controlled trial,27 and in another study, daily green tea
consumption has been associated with a lower incidence of
influenza infection.28 In our study, the absence of an
association between infection and either coffee or black tea
consumption as negative control exposures strengthens the
relevance of the association with green tea. As for the other
identified risk factors in our exploratory analysis, the effects
of green tea on influenza infection risk in this population
would need to be confirmed in a dedicated study, such as a
randomized controlled trial with a more detailed collection
of frequency and quantity of consumption.
Several other factors were identified as relevant by the
multimodel selection; however, they did not meet the
significance threshold in the final multivariable models.
Our study was an exploratory analysis of risk factors for
infection, and such factors should be considered as possibly
insightful results given a hypothesis-generating objective. For
example, we note the presence of several covariates regarding
household characteristics: proportion of 2010–2011 vaccine
recipients in the household and mean number of daily
handwashing in the household. These covariates, in addition
to proportion of household members always covering their
mouth while coughing, highlight the potential importance of
collective behaviors in the household to limit transmissions
at an individual level.
Infection rate was slightly higher in subjects under
15 years old, but the difference with other age groups was
not significant (P = 010). Contrary to the first pandemic
wave in 2009,9 age was not identified as a factor associated
with infections in the multimodel selection. A large propor-
tion of young subjects may have been infected during the
2009 wave, as evidenced by their high pre-epidemic GMT.
Furthermore, reported ILI during the 2009 pandemic wave
was associated with a lower infection rate in the multimodel
selection (this association disappeared after adjustment on
the pre-epidemic titer).
Other evidence pointing to a change in the susceptible
population during the second season is the absence of a
factor related to contact behaviors. Contacts at school, which
is very specific to the susceptible population during the first
H1N1pdm09 risk factors in the general population
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season,9 were not associated with infection in this present
analysis likely because the susceptible population during the
second year did not have such specific contact behaviors.
However, it is possible that either the definition of contact
type9 or the duration was not a relevant measure of contacts
likely to favor virus transmission. Regardless, this negative
result is a reminder that measures to limit direct contacts
may have minimal impact on transmission via aerosols29 or
fomites.30
Strengths and limitations
To our knowledge, this cohort is the first attempt to
simultaneously study such a large amount of variables
regarding individual, household, and environmental deter-
minants of influenza in the general population. The major
challenge in this exploratory analysis was to identify the most
relevant factors while avoiding spurious associations. The
multimodel selection allowed us to select a limited set of
covariates according to their relevancy in multivariable
analysis, thus avoiding the biases linked to univariable
screening. The final model selection was therefore conducted
in a restricted number of covariates, with a type I error
comparable to most epidemiological studies. Multimodel
selection also accounted for model uncertainty, which may
be a more appropriate method of model selection compared
to those traditionally used in exploratory analyses.14
One limitation in this study is linked to the case definition.
Although the fourfold increase definition of seroconversions
is widely used, its lack of sensitivity has been demonstrated.31
Moreover, post-infectious HI titers are known to decrease
over time.9,32 The negative association between the post-
epidemic blood sample date and seroconversion rate may
partly explain the low seroconversion rate (195%) in
subjects with detected RNA; more infections may have been
identified by seroconversion if blood samples had been
collected right after the epidemic. This may have impaired
the power of our risk factor analysis and therefore limited the
likeliness to identify factors associated with infections.
However, as we found no association between the delay
between blood samples and main sociodemographic factors
or medical characteristics, we think this timing issue unlikely
to have involved confounding.
Specificity of seroconversions might also be questionable
but as no other A/H1N1 virus was identified during this
season, cross-reactions are unlikely in this analysis.
Virological samples were not obtained in households expe-
riencing only asymptomatic infections (concerning up to
67% of seasonal influenza infections33), which may explain
the differences in symptomatic rates according to the
diagnostic method. Interestingly, the best estimate of the
true symptomatic rate may be the one relying on subjects
with seroconversion (315%; CI: 187%, 463%), a result that
is comparable to a recently published estimation regarding
different seasonal strains (23%; 95% CI: 13–34).34
Finally, influenza A/H1N1pdm09 circulated in the pres-
ence of other viral strains during the 2010–2011 influenza
season: influenza A/H3N2 (81%) and influenza B (48%).35
In our study, RT-PCR and multiplex PCR were performed
on all samples and identified 37 influenza B infections
(including 10 coinfections with H1N1pdm09) and 44
seasonal influenza A infections (including 30 coinfections
with H1N1pdm09) of the 1121 studied subjects. At least 38
subjects infected with seasonal influenza did not meet the
case definition and were considered as “non-infected”;
therefore, this analysis identified risk factors associated with
H1N1pdm09 infections only. As a result of these limitations
in laboratory procedures, we can assume that our case
definition may have failed to identify some infected subjects,
whereas its specificity raises no major issue.
This exploratory risk factor analysis used a large amount of
covariates without any pre-specified hypothesis. Although this
data-driven approach provides an easy interpretation of
results, it relies on the assumption that risk factors are directly
associated with infections. Using the same database, we have
also performed a parallel study using a hypothesis-driven
approach in which data are used to support postulated causal
relationships in a structural model to identify factors associ-
ated with infections.36 While both approaches have their
respective strengths and limitations, they have allowed us to
exploit the richness of the CoPanFlu-France cohort data; these
complementary analyses help further understanding of the
determinants of influenza infection.
Conclusion
The data and biological samples collected within the CoPan-
Flu-France cohort study have allowed a comprehensive
analysis of the determinants of H1N1pdm09 infection during
the 2010–2011 season within households in the general
population. The broad scope of this exploratory analysis has
permitted to identify factors expected from previously
reported studies (pre-epidemic serologic titer, asthma, and
green tea) and to highlight the potential importance of
collective preventive behaviors in the household, including
the proportion of household covering their mouth when
coughing which was associated with H1N1pdm09 in the final
multivariable model. Additional analyses are being conducted
for this household cohort whose follow-up ended in late 2012
to provide complimentary insights for investigating risk
factors of infectious disease.
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